Failure of critically ill patients to metabolise midazolam

Anaesthesia

Volumn 42, Issue 6, 1987, Pages 619-626

  SHELLY, M P ^a   MENDEL, L ^a   PARK, G R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Hypnotics, benzodiazepines; midazolam; Pharmacokinetics

Indexed keywords

MIDAZOLAM;

CLINICAL ARTICLE; CRITICAL ILLNESS; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SEPTIC SHOCK; THERAPY;

AGED; CRITICAL CARE; FEMALE; HUMAN; HYPNOTICS AND SEDATIVES; KINETICS; MALE; MIDAZOLAM; MIDDLE AGE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0023181794     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1987.tb03086.x     Document Type: Article

References (28)

1. Prolonged infusion of chlormethiazole in intensive care
2. Influence of sedation on mortality in critically ill multiple trauraa patients
3. Mortality amongst multiple trauma patients admitted to an intensive therapy unit
4. Potential hazards of prolonged steroid anaesthesia
5. Midazolam: a water soluble benzodiazepine. Studies in volunteers
6. Midazolam kinetics
7. Benzodiazepines
8. Relationship between plasma concentration and effect of midazolam after oral and intravenous administration
9. Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit
10. Accumulation of midazolam in patients receiving mechanical ventilation
11. Midazolam in intensive care
12. Determination of midazolam and its 1‐hydroxymetabolite in plasma by gas chromatography with electron capture detection
13. APACHE II: a severity of disease classification System
14. The grading of sepsis
15. Assessing sedation
16. Chronopharmacokinetic study with prolonged infusion of midazolam
17. Pharmacokineties and bioavailability of midazolam in man
18. Evaluation of midazolam as an intravenous induction agent
19. Comparison of midazolam and diazepam in doses of comparable potency during gastroscopy
20. Age and nature of operation influence the pharmacokinetics of midazolam
21. The pharmacokinetics of midazolam in chronic renal failure patients
22. Influence of plasma proteins on the onset of hypnotic action of intravenous midazolam
23. Prolonged midazolam elimination half‐life
24. Midazolam pharmacodynamics and pharmacokinetics during acute hypovolemia
25. Circulatory responses to midazolam anesthesia: emphasis on canine splanchnie circulation
26. Haemodynamic changes during induction of anaesthesia with midazolam and diazepam (Valium) in patients undergoing coronary artery bypass surgery
27. Morphine pharmacokinetics in two children during and after liver transplantation
28. Morphine intoxication in renal failure: the role of morphine‐6‐glucoronide